Post-transplantation cyclophosphamide and cyclosporine A versus methotrexate and cyclosporine A for graft-versus-host disease prophylaxis after allogeneic peripheral stem cell transplantation in adult acute myeloid leukemia patients.
Mustafa O Sharaf El-DeenMoetaza M SolimanGamal Al-AzabMohamed SamraMohammad E E ShamsPublished in: Toxicology and applied pharmacology (2024)
PT-CY/CSA demonstrated a significant decrease in the rate of acute GVHD. However, it was associated with engraftment delay.
Keyphrases
- stem cell transplantation
- high dose
- acute myeloid leukemia
- end stage renal disease
- low dose
- ejection fraction
- newly diagnosed
- allogeneic hematopoietic stem cell transplantation
- chronic kidney disease
- prognostic factors
- peritoneal dialysis
- liver failure
- bone marrow
- respiratory failure
- stem cells
- extracorporeal membrane oxygenation
- patient reported